497 related articles for article (PubMed ID: 21468304)
1. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
[TBL] [Abstract][Full Text] [Related]
2. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial.
Thomas TK; Masaba R; Borkowf CB; Ndivo R; Zeh C; Misore A; Otieno J; Jamieson D; Thigpen MC; Bulterys M; Slutsker L; De Cock KM; Amornkul PN; Greenberg AE; Fowler MG;
PLoS Med; 2011 Mar; 8(3):e1001015. PubMed ID: 21468300
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral interventions for preventing breast milk transmission of HIV.
White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
[TBL] [Abstract][Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
7. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C;
Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418
[TBL] [Abstract][Full Text] [Related]
8. Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.
Paredes R; Cheng I; Kuritzkes DR; Tuomala RE;
AIDS; 2010 Jan; 24(1):45-53. PubMed ID: 19915448
[TBL] [Abstract][Full Text] [Related]
9. Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis.
Nelson JA; Fokar A; Hudgens MG; Compliment KJ; Hawkins JT; Tegha G; Kamwendo DD; Kayira D; Mofolo IA; Kourtis AP; Jamieson DJ; Van Der Horst CM; Fiscus SA
AIDS; 2015 Oct; 29(16):2131-8. PubMed ID: 26186128
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
[TBL] [Abstract][Full Text] [Related]
11. Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.
Hauser A; Sewangi J; Mbezi P; Dugange F; Lau I; Ziske J; Theuring S; Kuecherer C; Harms G; Kunz A
PLoS One; 2012; 7(2):e32055. PubMed ID: 22384138
[TBL] [Abstract][Full Text] [Related]
12. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
[TBL] [Abstract][Full Text] [Related]
13. Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique.
Antunes F; Zindoga P; Gomes P; Augusto O; Mahumane I; Veloso L; Valadas E; Camacho R
PLoS One; 2015; 10(7):e0131994. PubMed ID: 26161559
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk.
Inzaule SC; Weidle PJ; Yang C; Ndiege K; Hamers RL; Rinke de Wit TF; Thomas T; Zeh C
J Antimicrob Chemother; 2016 Jun; 71(6):1619-26. PubMed ID: 26953333
[TBL] [Abstract][Full Text] [Related]
15. Interventions for preventing late postnatal mother-to-child transmission of HIV.
Horvath T; Madi BC; Iuppa IM; Kennedy GE; Rutherford G; Read JS
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006734. PubMed ID: 19160297
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
McIntyre JA; Hopley M; Moodley D; Eklund M; Gray GE; Hall DB; Robinson P; Mayers D; Martinson NA
PLoS Med; 2009 Oct; 6(10):e1000172. PubMed ID: 19859531
[TBL] [Abstract][Full Text] [Related]
17. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
[TBL] [Abstract][Full Text] [Related]
18. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.
Kilewo C; Karlsson K; Ngarina M; Massawe A; Lyamuya E; Swai A; Lipyoga R; Mhalu F; Biberfeld G;
J Acquir Immune Defic Syndr; 2009 Nov; 52(3):406-16. PubMed ID: 19730269
[TBL] [Abstract][Full Text] [Related]
19. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
20. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
